Aclarion (NASDAQ:ACONW) Stock, Quote.Headers.trade-ideas

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Aclarion Inc

News

Iron Mountain Prices Upsized Offering By Way Of Private Placement Of $1.2B Of Its 6.25% Senior Notes Due 2033

Management

Stewart Information Services Agrees With CEO Frederick Eppinger To Amend And Restate His Employment Agreement, Extending Term For Another Three Years Through End Of 2028

Buybacks

RUSHA

Rush Enterprises Board Approves New Stock Repurchase Program Of Up To An Aggregate Of $150M Of Its Shares Of Class A Common Stock

The price of the<a href="https://www.benzinga.com/money/ripple-xrp-price-prediction"> XRP Token</a> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) from Ripple continues to climb thanks to optimism about the incoming White House administration and potential XRP ETFs, leading to the cryptocurrency recently flipping Tether and Solana to become the<a href="https://www.benzinga.com/24/12/42259460/xrp-beats-solana-to-become-4th-largest-crypto-by-market-cap-on-ripples-rlusd-approval-speculation"> third-largest crypto.</a>
What Happened: The price of XRP is up 87% over <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42296482/xrp-price-explodes-415-in-30-days-experts-analyze-why-xrp-is-going-up">the last seven days,</a> hitting new one-month and one-year highs.
The price action could be pinpointed to the anticipation of new leadership at the SEC, a financial institution that has often clashed with Ripple. A new change could see XRP and other cryptos face less or no government resistance moving forward, minimizing risk for investors.
Cryptocurrency experts also told Benzinga that Ripple's partnerships with financial institutions could be the reason for the increase in cryptocurrency&#8217;s price. The filing of several XRP ETFs also has investors excited about a potential larger spotlight on the cryptocurrency and more ways for investors to gain exposure.
While XRP has hit new one-year highs of $2.86 in the last 24 hours and the cryptocurrency is up over 280% year-to-date, the price still trails an all-time high of $3.84 set back in January 2018.
Also happening in 2018 was a Ripple community event at the three-day Consensus conference that saw Snoop Dogg booked as the entertainer and performer for the Ripple community.
Snoop Dogg, who has supported the cryptocurrency sector and non-fungible tokens, performed at a private invitation-only Consensus after-party from Ripple Labs on May 15, 2018.
The performance in New York saw several media outlets <a href="https://www.coindesk.com/markets/2018/05/19/at-ripples-snoop-dogg-party-a-search-for-xrp">cover </a>Snoop Dogg's appearance and the fact that he did not talk about investing in cryptocurrency during his performance. Instead, the event was much like a celebration for the XRP community. Ripple previously said they did not pay Snoop Dogg with XRP tokens for his appearance.
While celebrities endorsing cryptocurrencies is nothing new, Snoop Dogg's appearance may have marked an opportune moment to consider buying XRP—though the rapper offered no direct investment advice during the event.
Read Also: <a href="https://www.benzinga.com/24/11/42225289/heres-how-much-100-invested-in-xrp-token-today-will-be-worth-if-crypto-returns-to-all-time-highs">Here&#8217;s How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs</a>
Investing $1,000 in XRP: Investors who learned about XRP for the first time with news of his appearance at the Ripple event, or thought that his appearance could signal optimism for the XRP token going forward may have considered buying the cryptocurrency.
A $1,000 investment at the high price of $0.7523 on May 15, 2018 could have bought 1,329.26 XRP. The $1,000 investment would be worth $3,429.49 today based on a price of $2.58 at the time of writing, up 242.9%.
XRP continues to be one of the most talked about cryptocurrency in recent months, and its continued strength and the potential approval of ETFs could lead to a higher price for the coin.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Image created using a photo from Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$XRP

If You Invested $1,000 In XRP Token When Snoop Dogg Performed At Ripple Community Event At Consensus 2018, Here's How Much You'd Have Today

He will continue to lead the company during the executive search process for his successor.

GXO Logistics Says CEO Malcolm Wilson Has Informed Board That He Plans To Retire In 2025

Pure Storage, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) shares are soaring after the company reported its third-quarter results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/12/n42301813/pure-storage-announces-third-quarter-fiscal-2025-financial-results">details from the report. </a>
The Details: Pure Storage reported quarterly earnings of 50 cents per share, which beat the analyst consensus estimate of 42 cents. Quarterly revenue came in at $831.07 million which beat the consensus estimate of $818.14 million and is an increase over sales of $762.84 million from the same period last year.
Pure Storage reported: 
<ul>
<li>Subscription services revenue of $376.4 million, up 22% year-over-year. </li>
<li>Subscription annual recurring revenue (ARR) of $1.6 billion, up 22% year-over-year. </li>
<li>Remaining performance obligations (RPO) of $2.4 billion, up 16% year-over-year.</li>
<li>Non-GAAP gross margin was 71.9%. </li>
<li>Non-GAAP operating income was $167.3 million. </li>
<li>Non-GAAP operating margin was 20.1%.</li>
<li>Operating cash flow of $97 million. </li>
<li>Free cash flow of $35.2 million</li>
</ul>
&#8220;Pure Storage has achieved another industry first in our journey of data storage innovation with a transformational design win for our DirectFlash technology in a top-four hyperscaler,&#8221; said Pure Storage CEO Charles Giancarlo. 
&#8220;This win is the vanguard for Pure Flash technology to become the standard for all hyperscaler online storage, providing unparalleled performance and scalability while also reducing operating costs and power consumption,&#8221; Giancarlo added. 
Read Next: <a href="https://www.benzinga.com/24/12/42298242/tiktok-shop-bags-more-than-100-million-in-black-friday-sales">TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead</a>
Outlook:&nbsp;Pure Storage sees fourth-quarter revenue of $867 million, versus the $856.93 million estimate, and fiscal 2025 revenue of $3.15 billion, versus the $3.13 billion estimate. 
PSTG Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Pure Storage shares are up 23.55% after-hours at $66.15 at the time of publication Tuesday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42300548/art-cashins-lessons-cuban-crisis-trades-to-timeless-wall-street-wit">Art Cashin&#8217;s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit</a></li>
</ul>
Photo: Courtesy of Pure Storage, Inc.

Earnings

After-Hours Center

Movers

Tech

PSTG

Pure Storage Shares Soar After Strong Q3, Q4 Guidance Above Estimates: Details

ATIP

NYSE To Begin Delisting Proceedings Against ATI Physical Therapy

Macro Economic Events

Commodities

Econ #s

Economics

Markets

USA API Weekly Crude Oil Stock 1.232M Barrel Build vs 2.060M Barrel Draw Est.; Draw Of 5.935M Barrels Prior

TCB is a St Louis, Missouri-based, privately held intermodal marketing company specializing in the movement of 40 and 53-foot containers across North America. The Company acquired TCB through its wholly-owned subsidiary Radiant Road and Rail, Inc. and structured the transaction similar to its previous transactions, with a portion of the expected purchase price payable in subsequent periods based on the future performance of the acquired operations.

RLGT

Radiant Logistics Acquires Assets And Operations Of TCB Transportation Associates, LLC For Undisclosed Terms; Strengthens Brokerage Platform With Enhanced Intermodal Capabilities

Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) reported third-quarter financial results after the market close on Tuesday. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/12/b42301576/okta-announces-third-quarter-fiscal-year-2025-financial-results">rundown of the report</a>.
Q3 Earnings: Okta reported third-quarter revenue of $665 million, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $649.7 million. The cloud-native cybersecurity company reported adjusted earnings of 67 cents per share, beating analyst estimates of 58 cents per share, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue and subscription revenue were both up 14% on a year-over-year basis. Remaining performance obligations totaled $3.66 billion at quarter&#8217;s end, up 19% year-over-year.
Net cash provided by operations was&nbsp;$159 million, up from $154 million in the prior year's quarter. The company generated free cash flow of $154 million in the quarter, up from $150 million year-over-year. Okta ended the quarter with $2.25 billion in cash, cash equivalents and short-term investments.
&#8220;Our solid third-quarter results were underpinned by continued strong profitability and cash flow. The focused investments we&#8217;ve made in our partner ecosystem, the public sector vertical, and large customers are materializing in our business with each of these areas contributing meaningfully to top-line growth,&#8221; said Todd McKinnon, co-founder and CEO of Okta.
&#8220;Okta&#8217;s commitment to innovation and elevating identity security is resonating with customers of all sizes as they look to Okta to modernize their identity infrastructure.&#8221;
What&#8217;s Next: Okta sees fourth-quarter revenue in the range of $667 million to $669 million versus estimates of $650.64 million. The company anticipates fourth-quarter adjusted earnings&nbsp;of 73 to 74 cents per share versus estimates of 67 cents per share.&nbsp;
Okta expects full-year revenue to be in the range of $2.595 billion to $2.597 billion versus estimates of $2.563 billion. The company expects full-year adjusted earnings to be between $2.75 and $2.76 per share versus estimates of $2.61 per share.
Management will hold a conference call with analysts and investors at 5 p.m. ET to further discuss the company&#8217;s quarterly performance.
OKTA Price Action: <a href="https://www.benzinga.com/quote/OKTA" target="_blank" rel="noreferrer noopener">Okta shares</a> were up 19.31% in after-hours, trading at $97.49 at the time of publication, per <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42298242/tiktok-shop-bags-more-than-100-million-in-black-friday-sales">TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead</a></li>
</ul>
Photo: Shutterstock.

Guidance

OKTA

Okta Q3 Earnings: Revenue Beat, EPS Beat, Strong Guidance, Shares Surge

The district court decision concludes the litigation initiated in July 2022 in response to Fresenius' submission of an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval of a generic version of CINVANTI.&nbsp;
As a result of the decision, Heron will seek an order from the Court prohibiting Fresenius from launching its generic CINVANTI until after the expiration of the patents in 2035. This decision is subject to appeal.

Legal

HRTX

Heron Therapeutics Says US District Court Ruled In Its Favor In Patent Litigation Against Fresenius Kabi With Respect To CINVANTI Injectable Emulsion

China responded swiftly on Tuesday to new U.S. restrictions on semiconductor technology exports by imposing tighter controls on critical minerals used in <a href="https://www.benzinga.com/topic/semiconductors">chip manufacturing</a>.
The move targets gallium, germanium, and antimony — essential materials for advanced electronics and defense applications, The Wall Street Journal <a href="https://www.wsj.com/world/asia/china-tightens-curbs-on-exports-of-materials-with-chip-making-applications-to-u-s-4348a02c?mod=latest_headlines">reports</a>.
What Happened: A day after the U.S. blacklisted 140 Chinese entities and restricted exports of memory chips vital to artificial intelligence, Beijing retaliated with export bans and reviews for U.S.-bound shipments of these minerals. The Chinese Ministry of Commerce justified the measures as necessary for national security.
China also cautioned its businesses against purchasing American chips due to reliability and safety concerns. 
The restricted minerals are critical to the U.S. economy and defense supply chains, with Beijing accounting for a significant portion of imports between 2019 and 2022. For instance, the U.S. relied on China for 80% of its antimony needs during this period, WSJ reports.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42299957/feds-kugler-sees-inflation-progress-but-warns-policy-is-not-on-a-preset-course">Fed&#8217;s Kugler Sees Inflation Progress But Warns: &#8216;Policy Is Not On A Preset Course&#8217;</a>
The new U.S. export controls, which <a href="https://www.benzinga.com/government/regulations/24/12/42265847/biden-targets-china-with-new-chip-restrictions-nvidia-slides">took effect Monday</a>, primarily target Chinese firms such as Naura Technology Group, Huawei-linked companies and equipment manufacturers. These measures also extend restrictions to non-U.S. chip suppliers reliant on American technologies, sparking concern among global players like Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>).
Why It Matters: The clash underscores the fragility of global supply chains and the geopolitical stakes tied to semiconductor dominance. With China tightening its grip on critical materials, the U.S. faces mounting pressure to diversify its supply sources. 
Experts warn these developments could reshape the global semiconductor landscape as companies and governments navigate new trade barriers. U.S. firms such as Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and KLA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) may feel the ripple effects alongside international players exempt from these restrictions, including Dutch firm ASM International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>).
ETFs such as the Invesco Semiconductors ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSI#NASDAQ">PSI</a>) and the SPDR S&amp;P Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XSD#NYSE">XSD</a>) could also feel the effects of these trade restrictions, given their exposure to impacted companies.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/12/42301885/south-korea-etfs-won-pare-losses-as-yoon-makes-u-turn-on-martial-law-declaration">South Korea ETFs, Won Pare Losses As Yoon Makes U-Turn On Martial Law Declaration</a></li>
</ul>
Photo by Fahroni via Shutterstock

Asia

Global

ASML

KLAC

LRCX

NVDA

PowerShares Exchange-Traded Fund Trust Dynamic Semiconductor Portfolio

China Retaliates Against US Chip Sanctions, Tightens Mineral Exports

This increases the current amount of shares available for repurchase to approximately eleven million.

Cabot Board Boosts Share Repurchase Authorization By 10M Shares

WIIM

NOTV

Inotiv shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.

THTX

Theratechnologies Resumes Production Of EGRIFTA SV Following Shutdown Of Facility To Address FDA Inspection

Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) reported third-quarter financial results after the market close on Tuesday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/24/12/b42301590/salesforce-announces-third-quarter-fiscal-2025-results">from the quarter</a>.
Q2 Earnings:&nbsp;Salesforce reported third-quarter revenue of $9.44 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $9.35 billion. The enterprise cloud solutions company reported adjusted earnings of $2.41 per share, missing analyst estimates of $2.44 per share, according to<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">&nbsp;Benzinga Pro</a>.
Total revenue was up 8% on a year-over-year basis. Operating margin came in at 20%, and non-GAAP operating margin was 33.1%. Cash flow from operations was up 29% year-over-year and free cash flow was up 30% year-over-year to $1.78 billion. The company ended the quarter with remaining performance obligations of $26.4 billion, up 10% year-over-year.
&#8220;We delivered another quarter of exceptional financial performance across revenue, margin, cash flow and cRPO,&#8221; said Marc Benioff, chair and CEO of Salesforce.
&#8220;Agentforce, our complete AI system for enterprises built into the Salesforce Platform, is at the heart of a groundbreaking transformation. The rise of autonomous AI agents is revolutionizing global labor, reshaping how industries operate and scale.&#8221;
Don&#8217;t Miss: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42297318/american-exceptionalism-trade-gains-steam-as-dollar-sp-500-surge-in-lockstep-bank-of-america">&#8216;American Exceptionalism Trade&#8217; Gains Steam As Dollar, S&amp;P 500 Surge In Lockstep: Bank Of America</a>
Salesforce said it repurchased $1.2 billion worth of its stock in the quarter and returned $400 million to shareholders in the form of dividend payments. 
Guidance: Salesforce expects fourth-quarter revenue to be in the range of $9.9 billion to $10.1 billion. The company anticipates fourth-quarter adjusted earnings of $2.57 to $2.62 per share.&nbsp;
Salesforce sees full-year 2025 revenue of $37.8 billion to $38 billion. The company expects full-year adjusted earnings to be between $9.98 and $10.03 per share.
&#8220;With Agentforce, we&#8217;re not just witnessing the future — we&#8217;re leading it, unleashing a new era of digital labor for every business and every industry,&#8221; Benioff said.
Management will further discuss the quarter on a conference call with analysts and investors at 5 p.m. E.T.
CRM Price Action: <a href="https://www.benzinga.com/quote/CRM" target="_blank" rel="noreferrer noopener">Salesforce shares</a> were up 7.72% in after-hours, trading at $357 at publication Tuesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Shutterstock.

Salesforce Q3 Earnings: Revenue Beat, EPS Miss, Free Cash Flow Up 30%, AI Driving 'Groundbreaking Transformation' And More

LUNR

Intuitive Machines shares are trading higher after the company announced a $65 million public offering of common stock alongside a $10 million private placement.

Multi-year collaboration aims to expand artificial intelligence (AI) adoption, foster innovation, and enhance industry-specific solutions for diverse business leaders.
 &nbsp;

AMZN

Genpact Enters Multi-year Strategic Collaboration Agreement With Amazon Web Services

<a href="https://www.globenewswire.com/Tracker?data=ihXjcEoWxhQAg0vsph5i2W0UcUBuBqIjhjCCJmE_LLeZu5DkxYjGvVtULhCy_oyrAi2UNg3Bmci7IMZHybtb2CXkXlxzvhwuMVcPLskmd8YxCbG_n-7P1GaO_3pEY5rR">Outlook Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year for LYTENAVA&#x2122; (bevacizumab gamma), the first ophthalmic formulation of bevacizumab authorized for the treatment of wet age-related macular degeneration (wet AMD) in adults, today announced that Russell Trenary has stepped down as the Company's President and Chief Executive Officer (CEO), effective immediately. Lawrence Kenyon, Executive Vice President, Chief Financial Officer and member of the board of directors, has been appointed Interim CEO.

OTLK

Outlook Therapeutics Announces Executive Leadership Transition; Russell Trenary Has Stepped Down As The Co's President And CEO, Effective Immediately. Lawrence Kenyon, Executive Vice President, CFO, Has Been Appointed Interim CEO

CRGY

Crescent Energy shares are trading lower after the company announced a public offering of 18 million shares of class A common stock.

Press Releases

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Health Care

General

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Events

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Comments

Aclarion

Aclarion (ACONW) Forecast

Aclarion (NASDAQ:ACONW) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga